๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A pocket calculator program for using Pozen's formula

โœ Scribed by Michael D. Hagen

Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
228 KB
Volume
16
Category
Article
ISSN
0010-4825

No coin nor oath required. For personal study only.

โœฆ Synopsis

Pozen's formula has been shown to improve diagnostic accuracy in patients with acute chest pain. This paper describes a short program for the HP-41CV calculator which reliably calculates acute ischemic heart disease probabilities using Pozen's formula.

Pozen's formula Acute ischemic heart disease probabilities

๐Ÿ“œ SIMILAR VOLUMES

A pocket calculator program for intraven
A pocket calculator program for intravenous requirements
โœ A. J. Rich; P. D. Wright ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 246 KB

## Abstract A program to calculate the 24-h intravenous requirements of water, nitrogen, energy and six electrolytes on a card-programmable pocket calculator is described. Comparison of calculator-generated requirements with intravenous feeding regimens prescribed by junior clinicians for 8 ill pat

A pocket calculator program for noninvas
A pocket calculator program for noninvasive assessment of cardiorespiratory function
โœ A.C.P. Powles; N.L. Jones ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 895 KB

A pocket calculator program is described which facilitates rapid evaluation of pulmonary function at rest and during exercise. It embodies the Fick Principle applied to carbon dioxide ; mixed venous carbon dioxide tension is measured by rebreathing, obviating the need for central venous or pulmonary

A pocket calculator program for predicti
A pocket calculator program for prediction of warfarin maintenance dose
โœ Bruce R. Canaday; William T. Sawyer ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 623 KB

A pocket calculator program for prediction ofpatient warfarin maintenance dose based on initial anticoagulant response is described. Four maintenance dose estimates are provided if a fixed initial dosing regimen (three 1Omg doses) is used and one estimate if any other regimen, which produces a proth